These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 22200508)
21. Oxidative stress and antioxidant status in patients with late-onset gestational diabetes mellitus. López-Tinoco C; Roca M; García-Valero A; Murri M; Tinahones FJ; Segundo C; Bartha JL; Aguilar-Diosdado M Acta Diabetol; 2013 Apr; 50(2):201-8. PubMed ID: 21327985 [TBL] [Abstract][Full Text] [Related]
22. Profile of inflammatory mediators in gestational diabetes mellitus: phenotype and genotype. Gueuvoghlanian-Silva BY; Torloni MR; Mattar R; de Oliveira LS; Scomparini FB; Nakamura MU; Daher S Am J Reprod Immunol; 2012 Mar; 67(3):241-50. PubMed ID: 22070425 [TBL] [Abstract][Full Text] [Related]
23. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome. Heinonen MV; Laaksonen DE; Karhu T; Karhunen L; Laitinen T; Kainulainen S; Rissanen A; Niskanen L; Herzig KH Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):626-33. PubMed ID: 19278844 [TBL] [Abstract][Full Text] [Related]
24. Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes. Saucedo R; Zarate A; Basurto L; Hernandez M; Puello E; Galvan R; Campos S Arch Med Res; 2011 May; 42(4):318-23. PubMed ID: 21820611 [TBL] [Abstract][Full Text] [Related]
25. The postpartum cardiovascular risk factor profile of women with isolated hyperglycemia at 1-hour on the oral glucose tolerance test in pregnancy. Retnakaran R; Qi Y; Sermer M; Connelly PW; Hanley AJ; Zinman B Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):706-12. PubMed ID: 21703831 [TBL] [Abstract][Full Text] [Related]
26. Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetes. Paradisi G; Ianniello F; Tomei C; Bracaglia M; Carducci B; Gualano MR; La Torre G; Banci M; Caruso A Gynecol Endocrinol; 2010 Jul; 26(7):539-45. PubMed ID: 20170346 [TBL] [Abstract][Full Text] [Related]
27. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus. Tsai PJ; Yu CH; Hsu SP; Lee YH; Huang IT; Ho SC; Chu CH Nutrition; 2005; 21(11-12):1095-9. PubMed ID: 16308131 [TBL] [Abstract][Full Text] [Related]
28. Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Qiu C; Williams MA; Vadachkoria S; Frederick IO; Luthy DA Obstet Gynecol; 2004 Mar; 103(3):519-25. PubMed ID: 14990416 [TBL] [Abstract][Full Text] [Related]
29. Fasting hyperinsulinemia associates with increased sub-clinical inflammation in first-degree relatives normal glucose tolerant women independently of the metabolic syndrome. Setola E; Monti LD; Lucotti P; Galluccio E; Oldani M; Bosi E; Piatti P Diabetes Metab Res Rev; 2009 Oct; 25(7):639-46. PubMed ID: 19685554 [TBL] [Abstract][Full Text] [Related]
30. Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis. Floreani A; Variola A; Niro G; Premoli A; Baldo V; Gambino R; Musso G; Cassader M; Bo S; Ferrara F; Caroli D; Rizzotto ER; Durazzo M Am J Gastroenterol; 2008 Aug; 103(8):1959-65. PubMed ID: 18564121 [TBL] [Abstract][Full Text] [Related]
31. Decreased high-molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of Type 2 diabetes. Retnakaran R; Connelly PW; Maguire G; Sermer M; Zinman B; Hanley AJ Diabet Med; 2007 Mar; 24(3):245-52. PubMed ID: 17305786 [TBL] [Abstract][Full Text] [Related]
32. [Tumor necrosis factor-alpha system in patients with gestational diabetes]. Kinalski M; Kuźmicki M; Telejko B; Bachórzewski R; Buraczyk M; Kretowski A; Kinalska I Przegl Lek; 2006; 63(4):173-5. PubMed ID: 17083157 [TBL] [Abstract][Full Text] [Related]
33. Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women. Zeman M; Jirak R; Jachymova M; Vecka M; Tvrzicka E; Zak A Neuro Endocrinol Lett; 2009; 30(3):387-95. PubMed ID: 19855365 [TBL] [Abstract][Full Text] [Related]
34. Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia. Masuyama H; Segawa T; Sumida Y; Masumoto A; Inoue S; Akahori Y; Hiramatsu Y BJOG; 2010 Feb; 117(3):314-20. PubMed ID: 20015306 [TBL] [Abstract][Full Text] [Related]
35. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors. You T; Yang R; Lyles MF; Gong D; Nicklas BJ Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E741-7. PubMed ID: 15562250 [TBL] [Abstract][Full Text] [Related]
36. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. Chu MC; Cosper P; Orio F; Carmina E; Lobo RA Am J Obstet Gynecol; 2006 Jan; 194(1):100-4. PubMed ID: 16389017 [TBL] [Abstract][Full Text] [Related]
37. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Mirza MA; Alsiö J; Hammarstedt A; Erben RG; Michaëlsson K; Tivesten A; Marsell R; Orwoll E; Karlsson MK; Ljunggren O; Mellström D; Lind L; Ohlsson C; Larsson TE Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):219-27. PubMed ID: 20966399 [TBL] [Abstract][Full Text] [Related]
38. Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. Negrato CA; Jovanovic L; Tambascia MA; Calderon Ide M; Geloneze B; Dias A; Rudge MV Diabetes Metab Res Rev; 2008; 24(4):324-30. PubMed ID: 18254163 [TBL] [Abstract][Full Text] [Related]
39. Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus. Lekva T; Michelsen AE; Aukrust P; Henriksen T; Bollerslev J; Ueland T Cardiovasc Diabetol; 2017 Jan; 16(1):5. PubMed ID: 28068986 [TBL] [Abstract][Full Text] [Related]
40. Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis. Popa C; Netea MG; de Graaf J; van den Hoogen FH; Radstake TR; Toenhake-Dijkstra H; van Riel PL; van der Meer JW; Stalenhoef AF; Barrera P J Rheumatol; 2009 Apr; 36(4):724-30. PubMed ID: 19273452 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]